Jump to content

Brady Dougan

The comprehensive free global encyclopedia of CEOs, corporate leadership, and business excellence
Brady W. Dougan
Born
Urbana, Illinois, U.S.
NationalityAmerican
EducationUniversity of Chicago (BA, 1981; MBA, 1982)
OccupationBanker, businessman
CompanyExos Securities
TitleChairman and Chief Executive Officer
SpouseTomoko Hamada (m. 1988; div. 2005); Laura E. Niklason
Children2

Brady William Dougan (born August 1959) is an American banker and businessman. He was group chief executive officer of Credit Suisse Group AG and its operating bank, Credit Suisse AG, from May 2007 to June 2015, the first American to run the Swiss institution alone, after rising through its securities and investment banking businesses over the preceding seventeen years.[1][2]

Dougan's eight years as chief executive spanned the 2008 global financial crisis, which the bank weathered by raising capital privately rather than taking direct state assistance, and a 2014 guilty plea in a United States federal court to conspiring to help American clients evade tax, for which the bank agreed to pay roughly $2.6 billion in fines, restitution and penalties to U.S. authorities.[3] The guilty plea was entered by the bank itself; Dougan was not among the employees criminally charged in the underlying investigation.[3] Dougan nonetheless told a U.S. Senate subcommittee in February 2014 that a group of employees had helped clients evade tax, and he faced public criticism over the affair, including from a shareholder at the bank's own annual meeting, before its board announced in March 2015 that he would be replaced.[2]

Dougan left the bank at the end of June 2015 and was succeeded by Tidjane Thiam, formerly of the UK insurer Prudential plc.[4] Since July 2015 he has been chairman and chief executive of Exos, a privately held financial technology and broker-dealer group also known as Exos Financial, which he co-founded and which operates through the registered broker-dealer Exos Securities LLC.[5] He has also been a director of the regenerative-medicine company Humacyte, Inc. since 2005, chairing its board from 2019 to 2021, and he serves on the Board of Trustees of the University of Chicago, his alma mater.[5][6]

Early life and education

Dougan was born in Urbana, Illinois, in 1959, the youngest of five children of a railway dispatcher; a corporate filing with the United Kingdom's Companies House records his date of birth only as August 1959.[2][7] When he was about seven years old, his family moved to Murphysboro, Illinois, a coal mining and farming town in the southern part of the state.[2]

He attended the University of Chicago, where he worked weekend and evening shifts at the city's Central National Bank while studying, and graduated with a Bachelor of Arts in economics in 1981.[2] He stayed at the university for a fifth year to complete a Master of Business Administration in finance, awarded in 1982.[1][2] After graduating, he joined Bankers Trust in New York, working first in investment banking and then in a newly created derivatives unit, before moving to Japan at the age of twenty-four, where he helped build the bank's bond underwriting business and was made a managing director in 1987.[2] Colleagues later recalled that Dougan continued to keep notes of meetings with staff and clients in red and blue Japanese notebooks for decades after leaving Tokyo.[2]

Career

Bankers Trust (1982 to 1990)

Dougan spent the first part of his career at Bankers Trust, moving from New York to Tokyo as a young banker and rising to managing director there on the strength of the bond underwriting franchise he helped establish in Japan.[2]

Rise at Credit Suisse First Boston (1990 to 2004)

In 1990, Allen Wheat, who had left Bankers Trust to set up a new derivatives business called Credit Suisse Financial Products, recruited Dougan to join him.[2] By 1993, Wheat had become president of Credit Suisse First Boston (CSFB), and he moved Dougan from Tokyo to New York to co-head the bond underwriting business.[2] In 1996, Dougan took over CSFB's equities division, reporting to Oswald Gruebel, and told colleagues he aimed to lift the unit's annual profit to $1 billion; he reached that target a year ahead of schedule, in 1999.[2] He was promoted in 2000 to co-head of CSFB's investment banking and equities units, and the following year, when John Mack succeeded Wheat as chief executive of the securities business, Mack placed Dougan in charge of the combined bond and stock units; that same year CSFB cut roughly 10,000 jobs amid falling profit and regulatory inquiries into the technology-boom stock allocation practices that would later cost the firm a $100 million settlement with U.S. regulators.[2] Dougan was named global head of CSFB's securities division in 2001 and joined its executive board that year, then served as co-president of institutional securities at CSFB from 2002 to July 2004.[1]

Mack was ousted from the group's leadership in 2004 after pushing for CSFB to merge with a rival investment bank and after ordering Dougan to relocate to London; Gruebel then became sole chief executive of the group and put Dougan in charge of the investment bank.[2]

Chief executive of Credit Suisse First Boston (2004 to 2005)

Dougan was named chief executive of Credit Suisse First Boston in 2004, a role he held until CSFB was formally merged into the group in May 2005, after which he continued to run the renamed Credit Suisse First Boston division within the merged bank through the end of that year.[6] He had already joined the group's executive board in 2003.[6]

Head of investment banking and the Americas (2006 to 2007)

From January 2006, Dougan served as chief executive of the group's investment banking division, and from early in 2007 he also served as acting chief executive of its Americas region, a post he held until the end of July 2007.[1]

Group chief executive officer of Credit Suisse (2007 to 2015)

Dougan became group chief executive on 5 May 2007, succeeding Oswald Gruebel, who retired after a 38-year career at the bank.[1] Having joined the organisation seventeen years earlier, Dougan became the first American to lead the Swiss institution alone.[2] In its 2007 annual report, under his new leadership, the bank described five strategic priorities for the year ahead: deepening relationships with major clients across wealth, corporate and institutional segments; expanding an "integrated bank" model designed to generate revenue by having its banking, asset management and wealth management divisions work together; deploying capital in a disciplined manner; continuing to invest in growth markets; and attracting and developing talent.[1] At the end of Dougan's first year as chief executive, the group reported net income of 7,760 million Swiss francs, a market capitalisation of 76,024 million francs, and 48,100 full-time-equivalent employees, up from 44,900 a year earlier.[1]

The 2008 financial crisis struck within Dougan's first full year in charge. The bank reported a net loss of 8,218 million Swiss francs for 2008 as its market capitalisation fell to 33,762 million francs by year end.[8] Rather than seek government aid of the kind some other European banks accepted during the crisis, Dougan's bank raised a total of 10 billion Swiss francs in October 2008 from existing shareholders; Qatar Holding LLC, a vehicle of the Qatar Investment Authority, disclosed that its combined holding of shares and derivatives in the bank had reached 9.9 percent by the end of that month.[8] As part of its 2008 compensation process, the bank also introduced the Partner Asset Facility, under which senior investment bankers with the title of managing director or director received the majority of their deferred variable pay in the form of awards indexed to, and representing a first-loss interest in, a specified pool of illiquid assets originated within the investment bank, rather than in cash; the bank granted these awards, with a total notional value of 676 million Swiss francs, to employees on 21 January 2009.[8]

As UBS, the bank's domestic rival, faced scrutiny in 2008 over helping American clients evade tax, Dougan described his own bank's cross-border business with wealthy U.S. clients as "immaterial"; in 2011, asked about the same subject, he said the bank had operated "a really state-of-the-art compliant cross-border banking business."[2] Those public assurances were undercut in 2014: in February, Dougan told a U.S. Senate subcommittee that a small group of employees had in fact helped clients conceal assets from the Internal Revenue Service, and in May, the bank pleaded guilty in U.S. federal court to a single count of conspiracy to aid and assist American taxpayers in filing false returns (described more fully under Controversies, below).[2] In a related matter the same year, the bank agreed in March 2014 to pay $885 million to settle litigation brought by the U.S. Federal Housing Finance Agency over its sale of approximately $16.6 billion of residential mortgage-backed securities between 2005 and 2007.[9]

By the end of 2014, Dougan's final full year in charge, net income attributable to shareholders had fallen to 1,875 million Swiss francs, market capitalisation stood at 40,308 million francs, and the group employed 45,800 people on a full-time-equivalent basis.[9] On 10 March 2015, the bank announced that Dougan would step down as chief executive at the end of June 2015 and be succeeded by Tidjane Thiam, then group chief executive of Prudential plc.[4][9] In its 2014 annual report, the bank's chairman, Urs Rohner, thanked Dougan for "his tremendous commitment and unparalleled contribution over the years" after what the report called "an exceptional career of 25 years with Credit Suisse, including eight years as its CEO."[9] Speaking to the Wall Street Journal in Zurich shortly before his departure, a tired but relieved Dougan reflected: "Eight years as the CEO of a global bank is a long time."[10] The Guardian noted that Dougan's successor would also have to contend with reduced presence in investment banking relative to UBS and with a pending $10 billion U.S. lawsuit over pre-crisis mortgage-backed securities sales.[4]

Exos (2015 to present)

Since leaving the bank, Dougan has served as chairman and chief executive of Exos, which describes itself as a digital business-to-business finance platform founded in 2018 by Dougan and other finance and technology professionals.[11][5] Exos conducts its securities business through Exos Securities LLC, a subsidiary that traces its registration to a Delaware entity formed on 3 May 2017 under the name Auro TFP LP; that entity converted to a limited liability company and was renamed Exos Securities LLC on 29 March 2018, and its broker-dealer membership with the Financial Industry Regulatory Authority (FINRA) was approved on 13 February 2019.[12] Exos Securities is a wholly owned subsidiary of Exos Financial LLC, which is in turn majority owned by Exos TFP Holdings LLC; according to its own SEC filings, the broker-dealer is principally engaged in the purchase and sale of U.S. Treasury securities and exchange-traded futures contracts, and in equity trading, advisory and underwriting, transacting mainly with institutional counterparties and executing trades on an agency basis for funds managed by an affiliate, Exos Asset Management.[12] As of its most recent public SEC filing, dated 29 January 2026 and covering the year ended 30 November 2025, Exos Securities remained registered with the SEC and FINRA, listing its business address as 35 West 35th Street, New York.[13] That filing also disclosed significant financial difficulty at the broker-dealer subsidiary, discussed under Controversies, below.[12]

Board membership at Humacyte

Dougan has served on the board of directors of Humacyte, Inc., a biotechnology company that develops bioengineered human tissue, since 2005, when it was still a privately held company founded the previous year.[5][6] He chaired Humacyte's board from March 2019 until August 2021, when the company became publicly listed, and he has continued as a director since.[5]

Leadership and management style

Dougan's tenure was marked by a preference for raising capital from private investors rather than relying on government support. In October 2008, at the height of the financial crisis, Dougan's bank raised 10 billion Swiss francs from existing shareholders, including a new 9.9 percent stake taken by Qatar Holding LLC, instead of accepting the kind of direct state assistance that other European banks, including domestic rival UBS, took during the same period.[8] In the same period, Dougan's management restructured compensation for senior investment bankers through the Partner Asset Facility, tying part of their deferred pay directly to the performance of a pool of the bank's own illiquid legacy assets rather than paying it in cash, a design intended to give bankers a direct stake in winding down the risk left on the balance sheet from before the crisis.[8] The bank's annual reports from this period also describe Dougan pursuing an "integrated bank" strategy, under which the private banking, investment banking and asset management divisions were pushed to generate measurable "collaboration revenues" by referring clients and products to one another, with an internal target of more than 10 billion Swiss francs in such revenues a year by 2012.[1][9]

Addressing students at his alma mater, the University of Chicago, in 2011, Dougan offered a view of leadership motivation that was reported at the time: "A lot of people want to get to a senior position in a company because they are drawn by the fame, power and money. In my view, all of those are not very good reasons."[2] On his bank's most consequential regulatory problem, Dougan's own public position shifted markedly over time: from describing the cross-border business with American clients as "immaterial" in 2008, to defending it as "state-of-the-art compliant" in 2011, to acknowledging to a U.S. Senate subcommittee in February 2014 that a small group of employees had, in fact, assisted clients in evading U.S. tax. That evolution, and the guilty plea that followed three months after his Senate testimony, drew sustained criticism of Dougan's earlier public reassurances.[2]

Major deals and strategic decisions

Several transactions and strategic choices mark Dougan's tenure as chief executive. In October 2008, his bank raised 10 billion Swiss francs from existing shareholders rather than seek government assistance, with Qatar Holding LLC emerging as a new investor holding 9.9 percent of its shares and derivatives.[8] In January 2009, under Dougan's management, the bank granted its Partner Asset Facility awards, with a total notional value of 676 million Swiss francs, shifting part of senior bankers' pay from cash into claims on the bank's own illiquid asset pool.[8] In March 2014, Dougan's bank paid $885 million to settle the Federal Housing Finance Agency's litigation over the sale of roughly $16.6 billion of residential mortgage-backed securities issued between 2005 and 2007.[9] Two months later, in May 2014, the bank pleaded guilty to the federal tax-conspiracy charge and, together with related regulatory settlements, agreed to pay a total of about $2.6 billion: $1.8 billion to the U.S. Department of Justice, $100 million to the Federal Reserve, and $715 million to the New York State Department of Financial Services, on top of roughly $196 million it had already paid the U.S. Securities and Exchange Commission earlier that year for operating an unregistered cross-border brokerage and advisory business; its own annual report records the combined cost of the settlement, including the SEC component, as $2,815 million.[3][9] Finally, in March 2015, the board announced that Dougan would be succeeded as chief executive by Tidjane Thiam, effective at the end of June 2015.[4]

Financial and market performance

Annual reports filed with the U.S. Securities and Exchange Commission during Dougan's tenure record the following year-end figures:

Year end Net income (loss) attributable to shareholders (CHF million) Market capitalisation (CHF million) Full-time-equivalent employees
2007 7,760 76,024 48,100
2008 (8,218) 33,762 47,800
2013 2,326 43,526 46,000
2014 1,875 40,308 45,800

[1][8][9]

The figures show an institution that moved from record profitability in the mid-2000s into a large single-year loss during the 2008 crisis, then recovered to modest but reduced profitability for the remainder of Dougan's tenure, with year-end market value in 2014 running well below the level recorded at the end of his first year in charge.[1][8][9] Disclosed compensation shows Dougan's own pay moving in a similar pattern. His total reported compensation as chief executive was 22.3 million Swiss francs for 2007, composed of 6 percent salary, 10 percent cash bonus, 80 percent incentive share units and 4 percent other compensation.[1] For 2014, his final full year in the role, the compensation report recorded Dougan's total pay at 9.70 million Swiss francs, made up of 1.52 million francs in unrestricted cash, a short-term incentive award of 2.28 million francs, a long-term incentive award of 3.05 million francs, and fixed salary and benefits of 2.85 million francs; the compensation committee cited Dougan's handling of the U.S. cross-border settlement among the reasons for that year's award.[9] For 2013, the prior year, his total recorded compensation was 9.79 million francs.[9]

Board memberships and outside roles

  • Director, Humacyte, Inc., since 2005; chairman of the board, March 2019 to August 2021.[5]
  • Trustee, University of Chicago, since January 2013.[6]
  • Director, Barbara Dougan Foundation, as disclosed in the bank's 2014 annual report.[9]

Controversies

On 19 May 2014, during Dougan's tenure as chief executive, Credit Suisse AG pleaded guilty in the U.S. District Court for the Eastern District of Virginia to a single count of conspiracy to aid and assist U.S. taxpayers in filing false income tax returns with the Internal Revenue Service. The Department of Justice described it as the first global bank in more than a decade to admit to a crime in a U.S. courtroom.[3] The plea was entered by the bank itself, not by Dougan personally, and the Justice Department's own announcement is explicit that it is the Swiss corporation that pleaded guilty.[3] As part of the plea, the bank acknowledged that, for decades prior to and through 2009, it had operated an illegal cross-border banking business that knowingly and willfully helped thousands of U.S. clients open and maintain undeclared accounts and conceal offshore assets and income from the IRS. According to the statement of facts filed with the plea, its methods included assisting clients in using sham entities to hide undeclared accounts, soliciting IRS forms that falsely stated those sham entities were the beneficial owners of the assets involved, destroying account records sent to the United States for client review, using bank managers as unregistered investment advisors on undeclared accounts, providing hand-delivered cash in the United States to facilitate withdrawals, and issuing offshore credit and debit cards so clients could access undeclared funds.[3]

The settlement followed a years-long investigation that had already produced criminal indictments of eight bank employees beginning in February 2011, including a former manager, a former banker, and the bank's former representative officer in New York, with further defendants, including a former head of North America offshore banking, added in a superseding indictment in July 2011; two of those eight individuals had pleaded guilty by the time of the May 2014 plea.[3] None of the individuals named in the Justice Department's public announcement held an executive board role comparable to Dougan's, and he was not among those criminally charged.[3] Attorney General Eric Holder said at the time: "This case shows that no financial institution, no matter its size or global reach, is above the law. Credit Suisse conspired to help U.S. citizens hide assets in offshore accounts in order to evade paying taxes."[3] As group chief executive, Dougan was nonetheless the public face of the response: in February 2014, three months before the plea, he told a U.S. Senate subcommittee that a small group of employees had helped clients evade their U.S. tax obligations, a position that followed his own earlier public statements describing the cross-border business as "immaterial" in 2008 and "state-of-the-art compliant" in 2011.[2] At the bank's 2014 annual general meeting, a shareholder, Ernst Schmid, criticised Dougan directly over the affair, telling the meeting, as reported by Bloomberg News: "Fish stinks from the head down, more precisely, that's the head of CEO Brady Dougan."[2] In early 2015, shortly before the board announced his departure, the bank also revised its fourth-quarter 2014 results to include an additional litigation provision for mortgage-related claims.[2]

After Dougan's banking career ended, his later venture also encountered financial difficulty. In its financial statements for the year ended 30 November 2025, filed with the SEC on 29 January 2026, Exos Securities LLC disclosed that an arbitration decided against the firm in October 2023 had left it in capital deficiency, that it had remained out of compliance with regulatory net capital requirements throughout the 2025 fiscal year, and that under FINRA Rule 4110(b)(1) it had therefore been required to suspend its revenue-generating broker-dealer operations; the filing reported a net loss of $1.777 million for the year, member's equity of $450,000, and a net capital deficiency of $260,000, and stated that these conditions raised "substantial doubt" about the firm's ability to continue as a going concern absent additional capital from affiliates or third parties.[12] The filing noted that, in the second half of 2025, the arbitration liability and associated legal expenses were assigned to Exos Securities' parent company, Exos Financial.[12]

Personal life

Dougan married Tomoko Hamada in Tokyo, Japan, in November 1988; the couple had two children, born in 1992 and 1997.[14] Their marriage was dissolved by a Connecticut court on 17 June 2005, under a stipulated judgment dividing nearly $80 million in assets, including a $15,325,000 cash payment to Tomoko Hamada Dougan in two installments, the second of which was to be paid by 16 June 2006.[14] At the time of the settlement, Dougan was reported to have a gross weekly income of $384,615, and the couple's Greenwich, Connecticut, home was valued at $9.6 million.[15]

A dispute over interest on the late second installment, which Dougan paid twelve days after the deadline, led to further litigation. The Appellate Court of Connecticut ruled in Hamada Dougan's favor on 19 May 2009, holding that the interest provision of the couple's settlement was enforceable as written; Dougan then appealed to the Connecticut Supreme Court, which heard arguments in the case in March 2011.[14][15] Dougan was, at the time, a long-time resident of Greenwich, Connecticut.[15]

Dougan is now married to Laura E. Niklason, a physician-scientist who holds a Ph.D. in biophysics from the University of Chicago and an M.D. from the University of Michigan, and who founded the predecessor of Humacyte, Inc. in 2004 and has served as the company's president and chief executive officer since 2020.[5] Niklason was formerly the Nicholas M. Greene Professor of Anesthesiology and Biomedical Engineering at Yale University and has been elected to the National Academy of Medicine and the National Academy of Engineering.[5] Both Dougan and Niklason sit on Humacyte's board of directors, and the company's securities filings describe the two as a married couple who may be deemed to share beneficial ownership of certain Humacyte shares and stock options held of record by each of them.[5]

See also

References

  1. ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 <ref>"Credit Suisse Group and Credit Suisse, Annual Report 2007 (Form 20-F)".Credit Suisse Group, filed with the U.S. Securities and Exchange Commission.20 March 2008.Retrieved 28 September 2026.</ref>
  2. ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 <ref>Abelson, Max."How Brady Dougan's Climb Up a Swiss Peak Ended: Timeline".9 March 2015.Retrieved 28 September 2026.</ref>
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 <ref>"Credit Suisse Pleads Guilty to Conspiracy to Aid and Assist U.S. Taxpayers in Filing False Returns".U.S. Department of Justice, Office of Public Affairs.19 May 2014.Retrieved 28 September 2026.</ref>
  4. ↑ 4.0 4.1 4.2 4.3 <ref>"Prudential's Tidjane Thiam to take top role at Credit Suisse".10 March 2015.Retrieved 28 September 2026.</ref>
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 <ref>"Humacyte, Inc. Notice of 2026 Annual Meeting of Stockholders and Proxy Statement".Humacyte, Inc., filed with the U.S. Securities and Exchange Commission.28 April 2026.Retrieved 28 September 2026.</ref>
  6. ↑ 6.0 6.1 6.2 6.3 6.4 <ref>"Brady W. Dougan".Credit Suisse Group AG.26 June 2014.Retrieved 28 September 2026.</ref>
  7. ↑ <ref>"Brady William Dougan, personal appointments".Companies House, UK Government.Retrieved 28 September 2026.</ref>
  8. ↑ 8.0 8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 <ref>"Credit Suisse Group and Credit Suisse, Annual Report 2008 (Form 20-F)".Credit Suisse Group, filed with the U.S. Securities and Exchange Commission.24 March 2009.Retrieved 28 September 2026.</ref>
  9. ↑ 9.00 9.01 9.02 9.03 9.04 9.05 9.06 9.07 9.08 9.09 9.10 9.11 <ref>"Credit Suisse Group and Credit Suisse, Annual Report 2014 (Form 20-F)".Credit Suisse Group AG, filed with the U.S. Securities and Exchange Commission.20 March 2015.Retrieved 28 September 2026.</ref>
  10. ↑ <ref>Letzing, John."Brady Dougan, A Financial Crisis Survivor, Nears End of Tenure at Credit Suisse".10 March 2015.Retrieved 28 September 2026.</ref>
  11. ↑ <ref>"Exos Financial".Exos Financial LLC.Retrieved 28 September 2026.</ref>
  12. ↑ 12.0 12.1 12.2 12.3 12.4 <ref>"Exos Securities LLC, Statement of Financial Condition, November 30, 2025".Exos Securities LLC, filed with the U.S. Securities and Exchange Commission.29 January 2026.Retrieved 28 September 2026.</ref>
  13. ↑ <ref>"Exos Securities LLC, Form X-17A-5 (FOCUS Report) filing index".U.S. Securities and Exchange Commission.29 January 2026.Retrieved 28 September 2026.</ref>
  14. ↑ 14.0 14.1 14.2 <ref>"Dougan v. Dougan, Appellate Court of Connecticut, No. 28711".FindLaw, Appellate Court of Connecticut.19 May 2009.Retrieved 28 September 2026.</ref>
  15. ↑ 15.0 15.1 15.2 <ref>"Conn. court hears Credit Suisse CEO's divorce case".22 March 2011.Retrieved 28 September 2026.</ref>